{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T20:09:55Z","timestamp":1770062995336,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T00:00:00Z","timestamp":1586131200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T00:00:00Z","timestamp":1586131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001325","name":"Cancer Association of South Africa","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001325","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001322","name":"Medical Research Council of South Africa","doi-asserted-by":"crossref","award":["None"],"award-info":[{"award-number":["None"]}],"id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Esophageal squamous cell carcinoma (ESCC) is an aggressive cancer with one of the highest world incidences in the Eastern Cape region of South Africa. Several genome wide studies have been performed on ESCC cohorts from Asian countries, North America, Malawi and other parts of the world but none have been conducted on ESCC tumors from South Africa to date, where the molecular pathology and etiology of this disease remains unclear. We report here tumor associated copy number changes observed in 51 ESCC patients\u2019 samples from the Eastern Cape province of South Africa.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We extracted tumor DNA from 51 archived ESCC specimens and interrogated tumor associated DNA copy number changes using Affymetrix\u00ae 500\u2009K SNP array technology. The Genomic Identification of Significant Targets in Cancer (GISTIC 2.0) algorithm was applied to identify significant focal regions of gains and losses. Gains of the top recurrent cancer genes were validated by fluorescence in situ hybridization and their protein expression assessed by immunohistochemistry.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Twenty-three significant focal gains were identified across samples. Gains involving the <jats:italic>CCND1, MYC, EGFR<\/jats:italic> and <jats:italic>JAG1<\/jats:italic> loci recapitulated those described in studies on Asian and Malawian cohorts. The two most significant gains involved the chromosomal sub-bands 3q28, encompassing the <jats:italic>TPRG1<\/jats:italic> gene and 11q13.3 including the <jats:italic>CTTN<\/jats:italic>, <jats:italic>PPFIA1<\/jats:italic>and <jats:italic>SHANK2<\/jats:italic> genes<jats:italic>.<\/jats:italic> There was no significant homozygous loss and the most recurrent hemizygous deletion involved the <jats:italic>B3GAT1<\/jats:italic> gene on chromosome 11q25. Focal gains on 11q13.3 in 37% of cases (19\/51), consistently involved <jats:italic>CTTN<\/jats:italic> and <jats:italic>SHANK2<\/jats:italic> genes. Twelve of these cases (23,5%), had a broader region of gain that also included the <jats:italic>CCND1<\/jats:italic>, <jats:italic>FGF19, FGF4<\/jats:italic> and <jats:italic>FGF3<\/jats:italic> genes. <jats:italic>SHANK2<\/jats:italic> and <jats:italic>CTTN<\/jats:italic> are co-amplified in several cancers, these proteins interact functionally together and are involved in cell motility. Immunohistochemistry confirmed both Shank2 (79%) and cortactin (69%) protein overexpression in samples with gains of these genes. In contrast, cyclin D1 (65%) was moderately expressed in samples with <jats:italic>CCND1<\/jats:italic> DNA gain.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study reports copy number changes in a South African ESCC cohort and highlights similarities and differences with cohorts from Asia and Malawi. Our results strongly suggest a role for <jats:italic>CTTN<\/jats:italic> and <jats:italic>SHANK2<\/jats:italic> in the pathogenesis of ESCC in South Africa.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-020-06788-3","type":"journal-article","created":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T15:04:22Z","timestamp":1586185462000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Landscape of copy number aberrations in esophageal squamous cell carcinoma from a high endemic region of South Africa"],"prefix":"10.1186","volume":"20","author":[{"given":"Jacqueline","family":"Brown","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej J.","family":"Stepien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Willem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,6]]},"reference":[{"issue":"18","key":"6788_CR1","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1016\/j.ejca.2009.09.018","volume":"45","author":"F Islami","year":"2009","unstructured":"Islami F, Kamangar F, Nasrollahzadeh D, M\u00f8ller H, Boffetta P, Malekzadeh R. Oesophageal cancer in Golestan Province, a high-incidence area in northern Iran - a review. Eur J Cancer. 2009;45(18):3156\u201365.","journal-title":"Eur J Cancer"},{"issue":"2","key":"6788_CR2","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1053\/j.gastro.2017.08.023","volume":"154","author":"CC Abnet","year":"2018","unstructured":"Abnet CC, Arnold M, Wei W. Epidemiology of esophageal squamous cell carcinoma. Gastroenterology. 2018;154(2):360\u201373.","journal-title":"Gastroenterology"},{"key":"6788_CR3","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1093\/annonc\/mdx279","volume":"28","author":"G Murphy","year":"2017","unstructured":"Murphy G, McCormack V, Abedi-Ardekani B, et al. International cancer seminars: a focus on esophageal squamous cell carcinoma. Ann Oncol. 2017;28:2086\u201393.","journal-title":"Ann Oncol"},{"issue":"10","key":"6788_CR4","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1002\/ijc.25246","volume":"127","author":"NI Somdyala","year":"2010","unstructured":"Somdyala NI, Bradshaw D, Gelderblom WCA, Parkin DM. Cancer incidence in a rural population of South Africa, 1998-2002. Int J Cancer. 2010;127(10):2420\u20139.","journal-title":"Int J Cancer"},{"issue":"11","key":"6788_CR5","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1038\/sj.bjc.6600338","volume":"86","author":"R Pacella-Norman","year":"2002","unstructured":"Pacella-Norman R, Urban MI, Sitas F, Carrara H, Sur R, Hale M, Ruff P, Patel M, Newton R, Bull D, Beral V. Risk factors for oesophageal, lung, oral and laryngeal cancers in black south Africans. Br J Cancer. 2002;86(11):1751\u20136.","journal-title":"Br J Cancer"},{"issue":"2","key":"6788_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/02652030601013471","volume":"24","author":"G Sun","year":"2007","unstructured":"Sun G, Wang S, Hu X, Su J, Huang T, Yu J, Tang L, Gao W, Wang J. Fumonisin B1 contamination of home-grown corn in high-risk areas for esophageal and liver cancer in China. Food Addit Contam. 2007;24(2):181\u20135.","journal-title":"Food Addit Contam"},{"issue":"3","key":"6788_CR7","first-page":"209","volume":"96","author":"T Matsha","year":"2006","unstructured":"Matsha T, Stepien A, Blanco-Blanco E, Brink LT, Lombard CJ, van Rensburg S, Erasmus RT. Self-induced vomiting \u2013 risk for oesophageal cancer? S Afr Med J. 2006;96(3):209\u20132012.","journal-title":"S Afr Med J"},{"key":"6788_CR8","unstructured":"GLOBOCAN 2012: Estimated cancer incidence mortality and prevalence worldwide in 2012. http:\/\/globocan.iarc.fr\/Pages\/fact_sheets_population.aspx."},{"issue":"14","key":"6788_CR9","doi-asserted-by":"publisher","first-page":"5908","DOI":"10.1158\/0008-5472.CAN-08-4622","volume":"69","author":"N Hu","year":"2009","unstructured":"Hu N, Wang C, Ng D, Clifford R, Yang HH, Tang Z, Wang Q, Han X, Giffen C, Goldstein AM, Taylor PR, Lee MP. Genomic characterization of esophageal squamous cell carcinoma from a high-risk population in China. Cancer Res. 2009;69(14):5908\u201317.","journal-title":"Cancer Res"},{"issue":"91","key":"6788_CR10","first-page":"92","volume":"509","author":"Y Song","year":"2014","unstructured":"Song Y, Li L, Ou Y, Gao Z, Li E, Li X, Zhang W, Wang J, Xu L, Zhou Y, Ma X, Liu L, et al. Identification of genomic alterations in oesophageal squamous cell cancer. Nature. 2014;509(91):92\u20136.","journal-title":"Nature"},{"issue":"5","key":"6788_CR11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/ng.2935","volume":"46","author":"D Lin","year":"2014","unstructured":"Lin D, Hao J, Nagata Y, Xu L, Shang L, Meng X, Sato Y, Okuno Y, Varela AM, Ding L, Garg M, Liu L, et al. Genomic and molecular characterization of esophageal squamous cell carcinoma. Nat Genet. 2014;46(5):467\u201375.","journal-title":"Nat Genet"},{"issue":"4","key":"6788_CR12","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.athoracsur.2012.01.064","volume":"93","author":"S Bandla","year":"2012","unstructured":"Bandla S, Pennathur A, Luketich JD, Beer DG, Lin L, Bass A, Godfrey TE, Litle VR. Comparative genomics of esophageal adenocarcinoma and squamous cell carcinoma. Ann Thorac Surg. 2012;93(4):1101\u20136.","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"6788_CR13","doi-asserted-by":"publisher","first-page":"e39797","DOI":"10.1371\/journal.pone.0039797","volume":"7","author":"J Ying","year":"2012","unstructured":"Ying J, Shan L, Li J, Zhong L, Xue L, Zhao H, Li L, Langford C, Guo L, Qiu T, Lu N, Tao Q. Genome-wide screening for genetic alterations in esophageal cancer by aCGH identifies 11q13 amplification oncogenes associated with nodal metastasis. PLoS One. 2012;7(6):e39797.","journal-title":"PLoS One"},{"issue":"11","key":"6788_CR14","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/ng.465","volume":"41","author":"AJ Bass","year":"2009","unstructured":"Bass AJ, Watanabe H, Mermel CH, Yu S, Perner S, Verhaak RG, Kim SY, Wardwell L, Tamayo P, Gat-Viks I, Ramos AH, et al. SOX2 is an amplified lineage survival oncogene in lung and esophageal squamous carcinomas. Nat Genet. 2009;41(11):1238\u201342.","journal-title":"Nat Genet"},{"key":"6788_CR15","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/path.4925","volume":"242","author":"W Dai","year":"2017","unstructured":"Dai W, Ko JMY, Choi SSA, Yu Z, Ning L, Zheng H, Gopalan V, Chan KT, Lee NP, Chan KW, Law SY, Lam AK, Lung ML. Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma. J Pathol. 2017;242:500\u201310.","journal-title":"J Pathol"},{"issue":"16","key":"6788_CR16","doi-asserted-by":"publisher","first-page":"e88755","DOI":"10.1172\/jci.insight.88755","volume":"1","author":"W Liu","year":"2016","unstructured":"Liu W, Snell JM, Jeck WR. Subtyping sub-Saharan esophageal squamous cell carcinoma by comprehensive molecular analysis. JCI Insight. 2016;1(16):e88755.","journal-title":"JCI Insight"},{"issue":"8","key":"6788_CR17","first-page":"1877","volume":"59","author":"L Du Plessis","year":"1999","unstructured":"Du Plessis L, Dietzsch E, Van Gele M, Van Roy N, Van Helden P, Parker IM, Mugwanya DK, De Groot M, Marx MP, Kotze MJ, Speleman F. Mapping of novel regions of DNA gain and loss by comparative genomic hybridization in esophageal carcinoma in the black and colored populations of South Africa. Cancer Res. 1999;59(8):1877\u201383.","journal-title":"Cancer Res"},{"issue":"24","key":"6788_CR18","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.3748\/wjg.v17.i24.2909","volume":"17","author":"J Brown","year":"2011","unstructured":"Brown J, Bothma H, Veale R, Willem P. Genomic imbalances in esophageal carcinoma cell lines involve Wnt pathway genes. World J Gastroenterol. 2011;17(24):2909\u201323.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"6788_CR19","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/sj.bjc.6602889","volume":"94","author":"EH van Beers","year":"2006","unstructured":"van Beers EH, Joosse SA, Ligtenberg MJ, Fles R, Hogervorst FBL, Verhoef S, Nederl PF. A multiplex PCR predictor for aCGH success of FFPE samples. Br J Cancer. 2006;94(2):333\u20137.","journal-title":"Br J Cancer"},{"issue":"3","key":"6788_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"1","author":"R Edgar","year":"2002","unstructured":"Edgar R, Domrachev M, Lash AE. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;1(3):207\u201310.","journal-title":"Nucleic Acids Res"},{"key":"6788_CR21","doi-asserted-by":"crossref","unstructured":"Jacobs S, Thompson ER, Nannya Y, Yamamoto G, Pillai R, Ogawa S, Bailey DK, Campbell IG. Genome-wide, high resolution detection of copy number, loss of heterozygosity and genotypes from formalin-fixed, paraffin embedded tumour tissue using microarrays. Cancer Res. 2007;67(6).","DOI":"10.1158\/0008-5472.CAN-06-3597"},{"issue":"5","key":"6788_CR22","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/ng0506-500","volume":"38","author":"M Reich","year":"2006","unstructured":"Reich M, Gould J, Lerner J, Tamayo P, Mesirov JP. Genepattern 2.0. Nat Genet. 2006;38(5):500\u20131.","journal-title":"Nat Genet"},{"issue":"4","key":"6788_CR23","doi-asserted-by":"publisher","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel CH, Shumacher SE, Hill B, Meyerson ML, Beroukhim R, Getz G. GISTIC 2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011;12(4):R41.","journal-title":"Genome Biol"},{"issue":"1","key":"6788_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1182\/bloodadvances.2018026419","volume":"3","author":"A Cornish","year":"2019","unstructured":"Cornish A, Hoang J, Dobbins PH, Law SE, Chubb PJ, Orlando D, Houlston G. Identification of recurrent noncoding mutations in B-cell lymphoma using capture hi-C. Blood Adv. 2019;3(1):21\u201332.","journal-title":"Blood Adv"},{"issue":"5","key":"6788_CR25","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.bbamcr.2006.07.001","volume":"1773","author":"H Yamaguchi","year":"2007","unstructured":"Yamaguchi H, Condeelis J. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta. 2007;1773(5):642\u201352.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"6788_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.canlet.2008.02.066","volume":"265","author":"AM Weaver","year":"2008","unstructured":"Weaver AM. Cortactin and tumor invasiveness. Cancer Lett. 2008;265(2):157\u201366.","journal-title":"Cancer Lett"},{"issue":"2","key":"6788_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/ejn.13129","volume":"43","author":"HD MacGillavry","year":"2016","unstructured":"MacGillavry HD, Kerr JM, Kassner J, Frost NA, Blanpied TA. Shank\u2013cortactin interactions control actin dynamics to maintain flexibility of neuronal spines and synapses. Eur J Neurosci. 2016;43(2):179\u201393.","journal-title":"Eur J Neurosci"},{"key":"6788_CR28","doi-asserted-by":"publisher","first-page":"24486","DOI":"10.1038\/srep24486","volume":"6","author":"H Pehkonen","year":"2016","unstructured":"Pehkonen H, von Nandelstadh P, Karhemo PR, et al. Liprin- alpha1 is a regulator of vimentin intermediate filament network in the cancer cell adhesion machinery. Sci Rep. 2016;6:24486.","journal-title":"Sci Rep"},{"key":"6788_CR29","doi-asserted-by":"publisher","first-page":"15290","DOI":"10.1038\/ncomms15290","volume":"8","author":"J Chang","year":"2017","unstructured":"Chang J, Tan W, Ling Z, Xi R, et al. Genomic analysis of oesophageal squamous-cell carcinoma identifies alcohol drinking-related mutation signature and genomic alterations. Nat Commun. 2017;8:15290.","journal-title":"Nat Commun"},{"issue":"9","key":"6788_CR30","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1002\/hed.25834","volume":"41","author":"P Ramos-Garc\u00eda","year":"2019","unstructured":"Ramos-Garc\u00eda P, Gonz\u00e1lez-Moles M\u00c1, Ay\u00e9n \u00c1, Gonz\u00e1lez-Ruiz L, Gil-Montoya JA, Ruiz-\u00c1vila I. Predictive value of CCND1\/cyclin D1 alterations in the malignant transformation of potentially malignant head and neck disorders: systematic review and meta-analysis. Head Neck. 2019;41(9):3395\u2013407.","journal-title":"Head Neck"},{"issue":"20","key":"6788_CR31","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1200\/JCO.2016.70.3934","volume":"35","author":"RD Petty","year":"2017","unstructured":"Petty RD, Dahle-Smith A, Stevenson DAJ, Osborne A, Massie D, Clark C, Murray GI, Dutton SJ, Roberts C, Chong IY, Mansoor W, Thompson J, Harrison M, Chatterjee A, Falk SJ, Elyan S, Garcia-Alonso A, Fyfe DW, Wadsley J, Chau I, Ferry DR, Miedzybrodzka Z. Gefitinib and EGFR gene copy number aberrations in esophageal Cancer. J Clin Oncol. 2017;35(20):2279\u201387.","journal-title":"J Clin Oncol"},{"key":"6788_CR32","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/gcc.20270","volume":"45","author":"K Freier","year":"2006","unstructured":"Freier K, Sticht C, Hofele C, Flechtenmacher C, Stange D, Puccio L, Toedt G, Radlwimmer B, Lichter P, Freier SJ. Recurrent Coamplification of cytoskeleton-associated genes EMS1 and SHANK2 with CCND1 in Oral squamous cell carcinoma. Genes Chromosom Cancer. 2006;45:118\u201325.","journal-title":"Genes Chromosom Cancer"},{"key":"6788_CR33","doi-asserted-by":"crossref","unstructured":"Wangarin H, Kristiansen G, Schlomm T, Stephan C, Gunia S, Zimpfer A, Weichart W, Sauter G, Erbersdobler A. CD57 Expression in Incidental, Clinically Manifest, and Metastatic Carcinoma of the Prostate. BioMed Res Int. 2014:356427.","DOI":"10.1155\/2014\/356427"},{"key":"6788_CR34","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1038\/s41598-018-21160-z","volume":"8","author":"F Suk","year":"2018","unstructured":"Suk F, Chang C, Lin R, et al. ZFP36L1 and ZFP36L2 inhibit cell proliferation in a cyclin D-dependent and p53-independent manner. Nat Sci Rep. 2018;8:2742.","journal-title":"Nat Sci Rep"},{"key":"6788_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.leukres.2018.02.017","volume":"68","author":"J Liu","year":"2018","unstructured":"Liu J, Lu W, Liu S, et al. ZFP36L2, a novel AML1 target gene, induces AML cells apoptosis and inhibits cell proliferation. Leuk Res. 2018;68:15\u201321.","journal-title":"Leuk Res"},{"key":"6788_CR36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/2045-3701-1-25","volume":"1","author":"S Ludwig","year":"2011","unstructured":"Ludwig S, Klitzsch A, Baniahmad A. The ING tumor suppressors in cellular senescence and chromatin. Cell Biosci. 2011;1:25.","journal-title":"Cell Biosci"},{"key":"6788_CR37","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/jso.23380","volume":"108","author":"X Lou","year":"2013","unstructured":"Lou X, Qi X, Zhang Y, Long H, Yang A. Decreased expression of microRNA-625 is associated with tumor metastasis and poor prognosis in patients with colorectal Cancer. J Surg Oncol. 2013;108:230\u20135.","journal-title":"J Surg Oncol"},{"issue":"6","key":"6788_CR38","first-page":"9560","volume":"8","author":"C Li","year":"2015","unstructured":"Li C, Li D, Che S, Ma K, Wang Y, Xia L, Dai X, Zhang G, Shen Y, Jiao W, Tian K. The decreased expression of miR-625 predicts poor prognosis of esophageal squamous cell carcinoma. Int J Clin Exp Med. 2015;8(6):9560\u20134.","journal-title":"Int J Clin Exp Med"},{"issue":"10","key":"6788_CR39","doi-asserted-by":"publisher","first-page":"5838","DOI":"10.1128\/MCB.18.10.5838","volume":"18","author":"Y Du","year":"1998","unstructured":"Du Y, Weed SA, Xiong WC, Marshall TD, Parsons JT. Identification of a novel cortactin SH3 domain-binding protein and its localization to growth cones of cultured neurons. Mol Cell Biol. 1998;18(10):5838\u201351.","journal-title":"Mol Cell Biol"},{"issue":"5","key":"6788_CR40","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/j.1442-2050.2008.00921.x","volume":"22","author":"KF Hsu","year":"2009","unstructured":"Hsu KF, Lin CK, Yu CP, Tzao C, Lee SC, Lee YY, Tsai WC, Jin JS. Cortactin, fascin, and survivin expression associated with clinicopathological parameters in esophageal squamous cell carcinoma. Dis Esophagus. 2009;22(5):402\u20138.","journal-title":"Dis Esophagus"},{"issue":"5","key":"6788_CR41","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/j.1442-2050.2007.00775.x","volume":"21","author":"NY Hsu","year":"2008","unstructured":"Hsu NY, Yeh KT, Chiang IP, Pai LY, Chen CY, Ho HC. Cortactin overexpression in the esophageal squamous cell carcinoma and its involvement in the carcinogenesis. Dis Esophagus. 2008;21(5):402\u20138.","journal-title":"Dis Esophagus"},{"issue":"3","key":"6788_CR42","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1007\/s11033-019-04712-y","volume":"46","author":"H Zhou","year":"2019","unstructured":"Zhou H, Cao T, Li WP, Wu G. Combined expression and prognostic significance of PPFIA1 and ALG3 in head and neck squamous cell carcinoma. Mol Biol Rep. 2019;46(3):2693\u2013701.","journal-title":"Mol Biol Rep"},{"issue":"7636","key":"6788_CR43","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nature20805","volume":"541","author":"CGAR Network","year":"2017","unstructured":"Network CGAR, Analysis Working Group: Asan University, BC Cancer Agency; Brigham and Women\u2019s Hospital, et al. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017;541(7636):169\u201375.","journal-title":"Nature"},{"issue":"5","key":"6788_CR44","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.jid.2016.01.013","volume":"136","author":"MM Asgari","year":"2016","unstructured":"Asgari MM, Wang W, Ioannidis NM, Itnyre J, Hoffmann T, Jorgenson E, Whittemore AS. Identification of susceptibility loci for cutaneous squamous cell carcinoma. J Invest Dermatol. 2016 May;136(5):930\u20137.","journal-title":"J Invest Dermatol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-06788-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-020-06788-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-06788-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T23:15:50Z","timestamp":1617664550000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-06788-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,6]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["6788"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-06788-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,6]]},"assertion":[{"value":"9 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study received ethics approval from the University of the Witwatersrand human research ethics committee, in accordance with the Declaration of Helsinki (Reference number: M090658). These samples were retrospective FFPE samples obtained from the archive of the histopathology department. Samples could not be linked to living individuals and therefore consent could not be obtained. The samples were de-identified for the purpose of this study to preserve patient anonymity in accordance with the regulations of the local ethics committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was waived as this study was a retrospective study performed on archived tissue samples that could not be linked to living individuals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"281"}}